Wolverine Trading’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.91M | Buy |
54,500
+6,000
| +12% | +$300K | ﹤0.01% | 1838 |
|
|
2025
Q2 | $2.6M | Buy |
48,500
+7,200
| +17% | +$366K | ﹤0.01% | 1502 |
|
|
2025
Q1 | $1.8M | Sell |
41,300
-8,000
| -16% | -$405K | ﹤0.01% | 1708 |
|
|
2024
Q4 | $2.77M | Buy |
49,300
+4,300
| +10% | +$268K | ﹤0.01% | 1691 |
|
|
2024
Q3 | $2.97M | Buy |
45,000
+21,100
| +88% | +$1.19M | ﹤0.01% | 1410 |
|
|
2024
Q2 | $1.01M | Sell |
23,900
-21,500
| -47% | -$1.18M | ﹤0.01% | 2185 |
|
|
2024
Q1 | $3.14M | Buy |
45,400
+8,900
| +24% | +$563K | ﹤0.01% | 1294 |
|
|
2023
Q4 | $2.7M | Buy |
+36,500
| New | +$2.39M | ﹤0.01% | 1492 |
|
|
2023
Q3 | – | Sell |
-34,800
| Closed | -$3.28M | – | 4666 |
|
|
2023
Q2 | $3.28M | Buy |
34,800
+9,100
| +35% | +$710K | ﹤0.01% | 1167 |
|
|
2023
Q1 | $1.7M | Sell |
25,700
-60,200
| -70% | -$3.87M | ﹤0.01% | 1475 |
|
|
2022
Q4 | $4.25M | Buy |
85,900
+69,400
| +421% | +$2.84M | 0.01% | 980 |
|
|
2022
Q3 | $547K | Buy |
+16,500
| New | +$680K | ﹤0.01% | 2526 |
|
|
2022
Q2 | – | Sell |
-19,200
| Closed | -$1.37M | – | 4858 |
|
|
2022
Q1 | $1.37M | Sell |
19,200
-19,300
| -50% | -$1.41M | ﹤0.01% | 2122 |
|
|
2021
Q4 | $3M | Sell |
38,500
-3,900
| -9% | -$344K | ﹤0.01% | 1528 |
|
|
2021
Q3 | $3.89M | Sell |
42,400
-2,200
| -5% | -$232K | ﹤0.01% | 1507 |
|
|
2021
Q2 | $5.71M | Buy |
44,600
+11,100
| +33% | +$1.32M | 0.01% | 1036 |
|
|
2021
Q1 | $4.14M | Sell |
33,500
-35,500
| -51% | -$4.86M | 0.01% | 1280 |
|
|
2020
Q4 | $9.34M | Buy |
69,000
+100
| +0.1% | +$12.1K | 0.01% | 717 |
|
|
2020
Q3 | $7.03M | Buy |
68,900
+5,200
| +8% | +$449K | 0.02% | 681 |
|
|
2020
Q2 | $5.48M | Sell |
63,700
-29,800
| -32% | -$2.38M | 0.01% | 760 |
|
|
2020
Q1 | $5.46M | Buy |
93,500
+7,400
| +9% | +$601K | 0.02% | 722 |
|
|
2019
Q4 | $7.91M | Buy |
86,100
+30,400
| +55% | +$2.67M | 0.02% | 791 |
|
|
2019
Q3 | $5.12M | Buy |
55,700
+700
| +1% | +$79.8K | 0.01% | 862 |
|
|
2019
Q2 | $6.49M | Sell |
55,000
-100
| -0.2% | -$10.1K | 0.02% | 743 |
|
|
2019
Q1 | $4.77M | Sell |
55,100
-22,100
| -29% | -$1.88M | 0.01% | 905 |
|
|
2018
Q4 | $4.72M | Sell |
77,200
-28,400
| -27% | -$1.95M | 0.01% | 847 |
|
|
2018
Q3 | $8.33M | Buy |
105,600
+10,500
| +11% | +$685K | 0.02% | 648 |
|
|
2018
Q2 | $3.83M | Hold |
95,100
| – | – | 0.01% | 1081 |
|
|
2018
Q1 | $3.83M | Sell |
95,100
-10,800
| -10% | -$527K | 0.01% | 1081 |
|
|
2017
Q4 | $5.56M | Sell |
105,900
-1,300
| -1% | -$69.4K | 0.02% | 794 |
|
|
2017
Q3 | $5.05M | Buy |
107,200
+6,500
| +6% | +$262K | 0.02% | 762 |
|
|
2017
Q2 | $3.59M | Buy |
100,700
+56,600
| +128% | +$1.75M | 0.02% | 866 |
|
|
2017
Q1 | $1.04M | Sell |
44,100
-29,700
| -40% | -$589K | 0.01% | 1682 |
|
|
2016
Q4 | $986K | Sell |
73,800
-23,700
| -24% | -$383K | ﹤0.01% | 1923 |
|
|
2016
Q3 | $1.72M | Sell |
97,500
-18,500
| -16% | -$326K | 0.01% | 1415 |
|
|
2016
Q2 | $1.31M | Buy |
+116,000
| New | +$874K | 0.01% | 1387 |
|
Other funds holding EXAS
Wolverine Trading's EXAS Position: Q3 2025 in Review
Wolverine Trading reduced its Exact Sciences (EXAS) stake by 46% in Q3 2025, selling an estimated $557K and leaving 12,906 shares worth $689K. The position accounts for ﹤0.01% of the portfolio, ranked #3317.
Wolverine Trading first reported a position in EXAS in Q2 2016 and has held it in 30 quarters since. The position peaked at $2.85M in Q4 2017. 567 funds tracked by Wall St. Rank hold EXAS as of Q3 2025.
- Wolverine Trading held 12,906 shares of Exact Sciences worth $689K as of Q3 2025.
- Wolverine Trading sold 11,155 Exact Sciences shares in Q3 2025, an estimated $557K.
- Exact Sciences made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #3317 holding.
- Wolverine Trading first reported a position in Exact Sciences in Q2 2016 and has held it in 30 quarters since.
- Wolverine Trading's Exact Sciences position peaked at $2.85M in Q4 2017.
- 567 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.